Location: United States.
Department affected: Production.
Based on news reporting.
Novo Nordisk has begun layoffs affecting approximately 300 employees in the United States as part of a strategic response to the intensifying competition in the weight-loss drug market. The company is adjusting its workforce to better align with market demands and operational efficiency. This decision comes amid a broader industry trend where pharmaceutical companies are reevaluating their positions in light of new entrants and changing consumer preferences. The layoffs are part of a larger restructuring effort aimed at maintaining Novo Nordisk's competitive edge in the evolving healthcare landscape.
Novo Nordisk cut 300 jobs affecting its Production team as of October 1, 2023.
That is roughly 0.7% of the 45,000 people Novo Nordisk employs.
LayoffTalk has tracked 37 layoff events at Novo Nordisk since October 2023, affecting a combined 43,047 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
Novo Nordisk cut 300 jobs on October 1, 2023. If you were part of this round, what was your experience? Others going through it are reading. You can post anonymously below.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.